Suspended by NYSE in Aug 2022
Company logo

BDR - Blonder Tongue Laboratories, Inc.

NYSE -> Technology -> Communication Equipment
Old Bridge, United States
Type: Equity

BDR price evolution
BDR
(in millions $) 1 May 2022 31 Jan 2022 30 Oct 2021 30 Jul 2021
Current assets
Cash $0.11 $0.27 $0.27 $0.34
Short term investments
Net receivables $1.39 $1.76 $1.77 $1.82
Inventory $4.97 $4.85 $4.08 $3.78
Total current assets $7.54 $7.68 $7.64 $7.11
Long term investments
Property, plant & equipment $2.04 $2.27 $0.62 $0.65
Goodwill & intangible assets
Total noncurrent assets $4.49 $4.79
Total investments
Total assets $11.53 $11.91 $12.13 $11.91
Current liabilities
Accounts payable $3.06 $2.26 $2.15 $2.21
Deferred revenue
Short long term debt
Total current liabilities $6.8 $6.06 $5.64 $5.51
Long term debt $1.55 $1.57 $0.22 $0.23
Total noncurrent liabilities $2.73 $2.9
Total debt
Total liabilities $9.12 $8.62 $8.38 $8.42
Shareholders' equity
Retained earnings -$28.46 -$27.31 -$26.38 -$26.18
Other shareholder equity -$0.93 -$0.93 -$0.95 -$0.95
Total shareholder equity
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020 30 Jan 2019
Current assets
Cash $0.27 $0.07 $0.57 $0.56
Short term investments
Net receivables $1.76 $1.74 $2.5 $2.65
Inventory $4.85 $4.06 $8.48 $6.17
Total current assets $7.68 $6.1 $12.17 $10.38
Long term investments
Property, plant & equipment $2.27 $0.43 $0.39 $2.89
Goodwill & intangible assets
Total noncurrent assets $5.03 $6.17 $5.22
Total investments
Total assets $11.91 $11.13 $18.35 $15.6
Current liabilities
Accounts payable $2.26 $2.01 $4.31 $1.52
Deferred revenue
Short long term debt
Total current liabilities $6.06 $5.53 $8.37 $8.26
Long term debt $1.57 $1.8 $0.05 $0.03
Total noncurrent liabilities $4.36 $2.62 $0.17
Total debt
Total liabilities $8.62 $9.89 $10.98 $8.43
Shareholders' equity
Retained earnings -$27.31 -$27.39 -$19.92 -$19.18
Other shareholder equity -$0.93 -$0.95 -$0.89 -$0.57
Total shareholder equity
(in millions $) 1 May 2022 31 Jan 2022 30 Oct 2021 30 Jul 2021
Revenue
Total revenue $3.34 $3.99 $4.17 $4.34
Cost of revenue
Gross Profit $0.94 $1.37 $1.5 $1.6
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1.96 $2.15 $2.88 $2.96
Operating income -$0.7 -$0.62
Income from continuing operations
EBIT
Income tax expense $0.01
Interest expense -$0.13 -$0.14 $0.12 $0.13
Net income
Net income -$1.15 -$0.93 -$0.2 $1.63
Income (for common shares)
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020 30 Jan 2019
Revenue
Total revenue $15.75 $16.38 $19.84 $21.71
Cost of revenue
Gross Profit $5.86 $3.02 $3.43 $8.42
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $8.82 $10.49 $4.31 $9.56
Operating income -$7.11 -$0.47 -$0.85
Income from continuing operations
EBIT
Income tax expense $0.01 $0.01 $0.01 -$0.08
Interest expense -$0.51 $0.34 $0.26 $0.56
Net income
Net income $0.08 -$7.47 -$0.74 -$1.34
Income (for common shares)
(in millions $) 1 May 2022 31 Jan 2022 30 Oct 2021 30 Jul 2021
Net income $1.01 $1.21
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$0.63 $0.13
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$0.09 -$0.07 -$0.06
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$0.24 $1.46 $0.9 $0.21
Effect of exchange rate
Change in cash and equivalents -$0.16 $0.2 $0.2 $0.28
(in millions $) 31 Jan 2022 30 Jan 2021 30 Jan 2020 30 Jan 2019
Net income -$7.47 -$0.74 -$1.34
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$3.21 -$6.54 $0.59
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$0.09 -$0.19 $9.47 -$0.1
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $1.46 $2.9 -$2.92 -$0.1
Effect of exchange rate
Change in cash and equivalents $0.2 -$0.5 $0.01 $0.39
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding 13.27M
Revenue $15.84M
EBITDA N/A
EBIT N/A
Net Income -$655.00K
Revenue Q/Q 2.74%
Revenue Y/Y 1.67%
P/E ratio 0.00
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share 0.01
EPS -$0.05
ROA -5.52%
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 1.11
Quick ratio 0.38